The antigenic domain 1 of human cytomegalovirus glycoprotein B contains an intramolecular disulphide bond

Journal of General Virology

Volumn 81, Issue 11, 2000, Pages 2659-2663

  Speckner, A ^a   Kropff, B ^a   Knor, S ^a   Mach, M ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; DISULFIDE; MONOCLONAL ANTIBODY; THIOL GROUP; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ANTIGEN BINDING; ANTIGEN RECOGNITION; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; DISULFIDE BOND; EUKARYOTE; HUMAN CYTOMEGALOVIRUS; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROKARYOTE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PURIFICATION;

EID: 0033762843     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-81-11-2659     Document Type: Article

References (23)

1. Human cytomegalovirus glycoproteins
2. Oligomerization of the human cytomegalovirus major envelope glycoprotein complex gB (gp55-116)
3. Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): Use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response
4. Epitope map of human immunodeficiency virus type 1 gp41 derived from 47 monoclonal antibodies produced by immunization with oligomeric envelope protein
5. Effect of cysteine substitutions on dimerization and interfragment linkage of human cytomegalovirus glycoprotein B (gp UL55)
6. A colorimetric method for determining low concentrations of mercaptans
7. High expression of human cytomegalovirus (HCMV)-gB protein in cells infected with a vaccinia-gB recombinant: The importance of the gB protein in HCMV immunity
8. Disulfide-bonded discontinuous epitopes on the glycoprotein of vesicular stomatitis virus
9. Structure and composition of a family of human cytomegalovirus glycoprotein complexes desegnated gC-1 (gB)
10. Distribution of linear antigenic sites on glycoprotein gp55 of human cytomegalovirus
11. Glycoprotein B of herpes simplex virus type 1 oligomerizes through the intermolecular interaction of a 28-amino-acid domain
12. Antibodies to recombinant-derived glycoprotein B after natural human cytomegalovirus infection correlate with neutralizing activity
13. Use of recombinant fusion proteins and monoclonal antibodies to define linear and discontinuous antigenic sites on the dengue virus envelope glycoprotein
14. Glycoprotein gp116 of human cytomegalovirus contains epitopes for straincommon and strain-specific antibodies
15. Disulfide bonds of herpes simplex virus type 2 glycoprotein gB
16. Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58/116 (gB), as determined with human monoclonal antibodies
17. Assembly of conformation-dependent neutralizing domains on glycoprotein B of human cytomegalovirus
18. Antibodies specific for the antigenic domain 1 (AD-1) of glycoprotein B (gpUL55) of human cytomegalovirus bind to different substructures
19. The humoral immune response against human cytomegalovirus is characterized by a delayed synthesis of glycoprotein-specific antibodies
20. Assay for thiols based on reactivation of papain
21. Antigenic domain 1 of human cytomegalovirus glycoprotein B induces a multitude of different antibodies which, when combined, results in incomplete virus neutralization
22. A continuous sequence of more than 70 amino acids is essential for antibody binding to the dominant antigenic site of glycoprotein gp58 of human cytomegalovirus
23. Mucosal antibodies to human cytomegalovirus glycoprotein B occur following both natural infection and immunization with human cytomegalovirus vaccines